CIK 0002070849 · Non-accelerated filer<br>Emerging growth company
BillionToOne, Inc.
Sign in to watch- Ticker
- BLLN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811082020
- Phone
- 650-460-2551
- Business address
- 1035 O'BRIEN DRIVE, MENLO PARK, CA
- 4 Planned sale SVP of Laboratory Operations sold 1,416 shares at $120.00 ($169,920)
- 4 Planned sale Chief Product Officer sold 8,000 shares at $110.00 ($880,000)
- 4 Planned sale See Remarks sold 2,832 shares at $101.47 ($287,363)
- 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $102.27 ($2,045,326)
- 4 Grant or award Director acquired 3,017 shares (grant or award)
- 4 Grant or award Director acquired 3,017 shares (grant or award)
- 4 Grant or award Director acquired 3,017 shares (grant or award)
- 4 Grant or award Director acquired 3,017 shares (grant or award)
- 4 Grant or award Director acquired 3,017 shares (grant or award)
- 4 Other disposition Director disposed of 450,779 shares (other)
- 4 Other disposition 10% owner disposed of 450,779 shares (other)
- 4 Planned sale Chief Product Officer sold 8,000 shares at an average $98.23 ($785,800)
- 4 Planned sale See Remarks sold 14,000 shares at an average $100.18 ($1,402,540)
- 4 Planned sale See Remarks sold 38,750 shares at an average $97.84 ($3,791,445)
- 4 Other disposition 10% owner disposed of 450,779 shares (other)
- 4 Other disposition Director disposed of 450,779 shares (other)
- 4 Conversion 10% owner acquired 7,707,188 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 4,896 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 3 of 5 · 87 filings